California Medical Board advertising rules — the marketing compliance guide

Which boards actually regulate California advertising

California takes a broader view than most states of who counts as a "healer" for the purposes of advertising regulation. Business & Professions Code Section 651 does not sit under one board — it sits under the umbrella of the California Department of Consumer Affairs and applies to every licensee of every healing-arts board. A physician under the Medical Board of California, a dentist under the Dental Board of California, an optometrist under the California State Board of Optometry, a chiropractor under the Board of Chiropractic Examiners, a psychologist under the California Board of Psychology, a physical therapist under the Physical Therapy Board of California — all sit under Section 651 in addition to their own board's specific rules.

The Medical Board of California enforces the physician-specific overlay. Its focus areas are specialty designation, delegation to non-physicians, telemedicine advertising, and the interaction between the MBC rule set and the corporate practice of medicine doctrine. The Dental Board of California enforces the dentist-specific overlay and shares an ADA-alignment standard for specialty claims with most other US states.

The federal baseline still applies to every California practice: HIPAA for Protected Health Information, the FTC Act for truthful advertising, TCPA for outbound calls and SMS, CAN-SPAM for commercial email, and ADA / Section 508 for website accessibility. California layers three things on top that materially change the risk profile.

• Parallel civil exposure under the Unfair Competition Law (B&P 17200). A Section 651 violation is often also a UCL violation, and a UCL action can be brought by a private plaintiff, a public prosecutor or the Attorney General. The remedy set includes injunction, restitution, and civil penalties.
• Stricter testimonial and endorsement disclosure than the FTC. California's disclosure standard for atypical results and paid endorsement predates the FTC's 2023 revisions and remains, in practical effect, stricter.
• Consumer Privacy Rights Act (CPRA) overlay on marketing data. California's privacy regime interacts with health-related advertising data in ways federal HIPAA does not. Non-PHI health-adjacent data (interest signals, condition-page visits without an authenticated identifier) still triggers CPRA obligations if the visitor is a California resident.

Complaint-driven enforcement is the operating model, as in most states. The board does not pre-approve advertising. Complaints are docketed, investigated, and — where appropriate — resolved with a citation, a formal accusation, or a settlement stipulation. Every disciplinary outcome becomes part of the licensee's public record on the Department of Consumer Affairs website.

What's different from the federal HIPAA / FTC baseline

The mental model for a California practice is that federal rules set a national floor, and California layers on a stricter state ceiling. Four specific deltas are worth internalising.

• Testimonial disclosure standard. Federal FTC endorsement rules (16 CFR Part 255) require clear disclosure of material connections and typical-vs-atypical distinctions. California's Section 651 disclosure standard is functionally equivalent and, in enforcement, tends to be applied more strictly at the local level.
• Unfair Competition Law overlay. The federal FTC Act does not create a private right of action. California's UCL does. That means a California healthcare advertising claim can be litigated by a private plaintiff — a competitor, a former patient, a class of consumers — in a way that the federal FTC Act cannot.
• Consumer privacy overlay. California's CPRA has data-minimisation, transparency, and opt-out obligations that attach to health-adjacent marketing data even when the data is not PHI under HIPAA. A California resident's interest signal on a condition page, captured for retargeting, may be subject to CPRA even if it is outside HIPAA.
• Corporate practice of medicine. California's CPOM doctrine is strong. Non-physician-owned entities may not employ physicians directly and must operate through the MSO / professional entity structure. Advertising that blurs the line — "our doctors" spoken by an MSO, "we treat patients" spoken by a management entity — draws board attention.

A California-specific review therefore checks four things federal review does not: does the ad meet the Section 651 disclosure standard, does it survive a UCL fair-competition test, does the data collection behind it meet CPRA, and does the entity structure permit the entity in the ad to make the claim it is making.

Aesthetic, medspa and cosmetic surgery specifics

California's medspa segment is large and heavily scrutinised. Section 651 applies fully to aesthetic advertising, and the Medical Board has focused enforcement attention on delegation, physician direction, and unlicensed practice-of-medicine issues that surface most often in aesthetic settings.

Physician direction and delegation

A California medspa performing procedures within the practice of medicine — injectables, laser treatments beyond permitted delegable procedures, energy-based devices in prescription categories — must be under the direction of a physician. Advertising that omits or obscures the physician's role, or that suggests the medspa itself is the licensee, invites board investigation. The safer construction names the physician medical director where relevant and describes delegate roles accurately.

Before-and-after imagery

Before-and-after photography in California should be unretouched other than for lighting normalisation, should depict the practice's own patient, should carry a "results not typical" disclosure where the shown outcome is atypical, and should be supported by a signed HIPAA authorisation referencing the specific image and the specific media. Stock imagery passed off as patient outcomes is a recurring source of California disciplinary actions.

Ownership structure and MSO branding

Non-physician-owned medspa brands operating through management service organisations must be careful that advertising describes the professional entity providing care, not just the MSO brand. Multi-location brands frequently trip on this by advertising under a marketing name that does not correspond to the professional entity registered with the state.

Primary care, GP and multi-specialty groups

California primary care and multi-specialty groups usually run cleaner from an advertising-rule perspective than aesthetic practices, but the exposure clusters into three predictable areas.

• Provider directory accuracy. Every physician profile page on the practice site should match the current Medical Board of California licence, active ABMS or equivalent certifications, and scope of practice on the day the page is served. Directory pages age quickly and are the largest source of stale-credential findings.
• Service-line claims. A service line advertised as available at a specific California location must actually be available at that location, with the personnel, the equipment, and the licensure on site. Capacity claims that outrun operational reality are misleading omissions.
• Enterprise brand claims. Multi-location brands running "the trusted choice of California families" or "serving California since 19XX" claims need substantiation for each element. A running substantiation register is the practical control.

The internal routine that keeps a multi-specialty group inside Section 651 is a monthly reconciliation between the credentialing office, the marketing team, and the compliance officer. The reconciliation confirms directory accuracy, service-line staffing, and the currency of every substantiated claim.